| A Recombinant Blood-Stage Malaria Vaccine Reduces Plasmodium falciparum Density and Exerts Selective Pressure on Parasite Populations in a Phase 1-2b … B Genton, I Betuela, I Felger, F Al-Yaman, RF Anders, A Saul, L Rare, ... The Journal of infectious diseases 185 (6), 820-827, 2002 | 618 | 2002 |
| Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults. FC Cooper DJ, McQuilten ZK, Nichol A, Ady B, Aubron C, Bailey M, Bellomo R ... N Engl J Med 377 (9), 1858-1857, 2017 | 200* | 2017 |
| Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant A Saul, G Lawrence, A Smillie, CM Rzepczyk, C Reed, D Taylor, ... Vaccine 17 (23-24), 3145-3159, 1999 | 191 | 1999 |
| Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children B Genton, F Al-Yaman, I Betuela, RF Anders, A Saul, K Baea, M Mellombo, ... Vaccine 22 (1), 30-41, 2003 | 175 | 2003 |
| A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant A Saul, G Lawrence, A Allworth, S Elliott, K Anderson, C Rzepczyk, ... Vaccine 23 (23), 3076-3083, 2005 | 142 | 2005 |
| Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea B Genton, F Al-Yaman, R Anders, A Saul, G Brown, D Pye, DO Irving, ... Vaccine 18 (23), 2504-2511, 2000 | 142 | 2000 |
| Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells DC Bishop, LE Clancy, R Simms, J Burgess, G Mathew, L Moezzi, ... Blood, The Journal of the American Society of Hematology 138 (16), 1504-1509, 2021 | 136 | 2021 |
| SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants F Tea, A Ospina Stella, A Aggarwal, D Ross Darley, D Pilli, D Vitale, ... PLoS medicine 18 (7), e1003656, 2021 | 136 | 2021 |
| Blood transfusion during pregnancy, birth, and the postnatal period. FJB Patterson JA, Roberts CL, Bowen JR, Irving DO, Isbister JP, Morris JM Obstet Gynecol. 123 (1), 126-33, 2014 | 113 | 2014 |
| Reduced oviposition of Boophilus microplus feeding on sheep vaccinated with vitellin RL Tellam, D Kemp, G Riding, S Briscoe, D Smith, P Sharp, D Irving, ... Veterinary Parasitology 103 (1-2), 141-156, 2002 | 97 | 2002 |
| Seroprevalence of 2009 pandemic influenza A (H1N1) virus in Australian blood donors, October–December 2009 J McVernon, K Laurie, T Nolan, R Owen, D Irving, H Capper, C Hyland, ... Eurosurveillance 15 (40), 2010 | 73 | 2010 |
| The 42-kilodalton rhoptry-associated protein of Plasmodium falciparum A Saul, J Cooper, D Hauquitz, D Irving, Q Cheng, A Stowers, ... Molecular and biochemical parasitology 50 (1), 139-149, 1992 | 66 | 1992 |
| A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP‐I trial (Editorial, p. 2759) MC Reade, DC Marks, R Bellomo, R Deans, DJ Faulke, JF Fraser, ... Transfusion 59 (9), 2794-2804, 2019 | 58 | 2019 |
| Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA. CM Rzepczyk, R Ramasamy, PC Ho, DA Mutch, KL Anderson, ... Journal of immunology (Baltimore, Md.: 1950) 141 (9), 3197-3202, 1988 | 54 | 1988 |
| Selection of an adjuvant for vaccination with the malaria antigen, MSA-2 D Pye, KL Vandenberg, SL Dyer, DO Irving, NH Goss, GC Woodrow, ... Vaccine 15 (9), 1017-1023, 1997 | 43 | 1997 |
| Characterization of excretory-secretory antigens of Fasciola hepatica DO Irving, MJ Howell Parasitology 85 (1), 179-188, 1982 | 41 | 1982 |
| Fimbriae of Bacteroides nodosus: protein engineering of the structural subunit for the production of an exogenous peptide PA Jennings, MM Bills, DO Irving, JS Mattick Protein Engineering, Design and Selection 2 (5), 365-369, 1989 | 40 | 1989 |
| Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. WE Collins, RF Anders, TK Ruebush 2nd, DJ Kemp, GC Woodrow, ... The American journal of tropical medicine and hygiene 44 (1), 34-41, 1991 | 39 | 1991 |
| Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma TK Stutchbury, F Al-Ejeh, GE Stillfried, DR Croucher, J Andrews, D Irving, ... Molecular Cancer Therapeutics 6 (1), 203-212, 2007 | 38 | 2007 |
| SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays GJ Walker, Z Naing, A Ospina Stella, M Yeang, J Caguicla, ... Viruses 13 (2), 247, 2021 | 37 | 2021 |
Allan SaulDirector of GSK Vaccines Institute for Global HealthAdresse e-mail validée de gsk.com
